The prevalence of anaemia depends on the definition: an example from the Aboriginal Birth Cohort Study

D Mackerras1, G Singh

  • 1Menzies School of Health Research, Casuarina, Northern Territory, Australia. Dorothy.Mackerras@foodstandards.gov.au

Insights

Different anaemia definitions from WHO and US lead to varied prevalence rates in Aboriginal children. This highlights potential issues in identifying groups for anaemia intervention programs.

Area of Science:

  • Paediatric Haematology
  • Public Health
  • Epidemiology

Background:

  • Anaemia diagnosis relies on haemoglobin and haematocrit cutoffs, with differing recommendations from the World Health Organization (WHO) and the United States (US).
  • Variations in these diagnostic criteria can impact the estimated prevalence of anaemia and the identification of at-risk populations.

Purpose of the Study:

  • To compare anaemia prevalence estimates using WHO and US criteria in Australian Aboriginal children.
  • To investigate the underlying reasons for discrepancies in prevalence rates between the two sets of criteria.

Main Methods:

  • A cross-sectional survey was conducted on 517 Australian Aboriginal children aged 9-13 years.
  • Data collection involved home interviews and blood sample analysis.

Main Results:

  • Anaemia prevalence varied significantly, ranging from 6% to 24.4% depending on the criteria used.
  • The WHO criteria identified 12-13-year-old girls as a high-prevalence group, while US criteria indicated 12-13-year-old boys as having the highest, though not statistically significant, prevalence.
  • Simulations revealed that inconsistent centiles in age-sex specific haemoglobin and haematocrit distributions underlie the WHO cutoffs, explaining the divergent results.

Conclusions:

  • The variability in anaemia diagnostic criteria can lead to misidentification of target groups for intervention programs.
  • Standardizing or carefully considering diagnostic criteria is crucial for effective public health strategies in paediatric anaemia.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...